Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

DeepSeek V4 ignites the token new wave XUNCE (03317) with a quarterly surge of 300%!

Peace talks fail to restart! Trump cancels US envoy's trip to Pakistan.
.png)
New stocks news | Zytpeptide Biologics has submitted an application to the Hong Kong Stock Exchange. Zweigru Peptide is expected to become the world's first approved monthly dosing GLP-1 RA peptide therapy to be listed on the market.
DeepSeek V4 ignites the token new wave XUNCE (03317) with a quarterly surge of 300%!

Peace talks fail to restart! Trump cancels US envoy's trip to Pakistan.

New stocks news | Zytpeptide Biologics has submitted an application to the Hong Kong Stock Exchange. Zweigru Peptide is expected to become the world's first approved monthly dosing GLP-1 RA peptide therapy to be listed on the market.
.png)
RECOMMEND

The Great Transformation Of The Hong Kong Automotive Market
23/04/2026

Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026

Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026


